Next Article in Journal
Atractylone in the Atractylodes macrocephala Rhizoma Essential Oil and Its Anti-Inflammatory Activity
Previous Article in Journal
Preparation of COPs Mixed Matrix Membrane for Sensitive Determination of Six Sulfonamides in Human Urine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Agrawal et al. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828

by
Pawan K. Agrawal
1,*,
Chandan Agrawal
1 and
Gerald Blunden
2
1
Natural Product Inc., 7963 Anderson Park Lane, Westerville, OH 43081, USA
2
School of Pharmacy and Biomedical Science, University of Portsmouth, Portsmouth PO1 2DT, UK
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(21), 7337; https://doi.org/10.3390/molecules28217337
Submission received: 17 October 2023 / Accepted: 21 October 2023 / Published: 30 October 2023
The journal retracts the article “Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?” [1].
Following publication, concerns were brought to the attention of the Editorial Office regarding significant overlap with a previously published work [2] with a different authorship group and without appropriate citation.
Adhering to our complaint’s procedure, an investigation was conducted by the Editorial Office and Editorial Board and confirmed the overlap, which included a number of identical sequences of references, abbreviations not commonly used in Molecules, as well as the lack of methodology that differentiates the current results from previous publications. This article is therefore retracted.
This retraction was approved by the Editor in Chief of the journal Molecules.
The authors disagree with this retraction.

References

  1. Agrawal, P.K.; Agrawal, C.; Blunden, G. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828. [Google Scholar] [CrossRef] [PubMed]
  2. Fuzimoto, A.D. An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment. J. Integr. Med. 2021, 19, 375–388. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Agrawal, P.K.; Agrawal, C.; Blunden, G. RETRACTED: Agrawal et al. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828. Molecules 2023, 28, 7337. https://doi.org/10.3390/molecules28217337

AMA Style

Agrawal PK, Agrawal C, Blunden G. RETRACTED: Agrawal et al. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828. Molecules. 2023; 28(21):7337. https://doi.org/10.3390/molecules28217337

Chicago/Turabian Style

Agrawal, Pawan K., Chandan Agrawal, and Gerald Blunden. 2023. "RETRACTED: Agrawal et al. Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment? Molecules 2022, 27, 3828" Molecules 28, no. 21: 7337. https://doi.org/10.3390/molecules28217337

Article Metrics

Back to TopTop